EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanozyme‐Enabled Treatment of Cardio‐ and Cerebrovascular Diseases

Yihong Zhang, Wanling Liu, Xiaoyu Wang, Yufeng Liu, Hui Wei iD

Small · 2023-03 · 19 (13)

DOI: 10.1002/smll.202204809 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, online erschienen am 03.10.2022. Verfasst von Yihong Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Engineering and Applied Sciences, Nanjing National Laboratory of Microstructures, Jiangsu Key Laboratory of Artificial Functional Material…. Hauptthemen laut MEDLINE: Cerebrovascular Disorders, Cardiovascular Diseases. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 108 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardio‐ and cerebrovascular diseases are two major vascular‐related diseases that lead to death worldwide. Reactive oxygen species (ROS) play a vital role in the occurrence and exacerbation of diseases. Excessive ROS induce cellular context damage and lead to tissue dysfunction. Nanozymes, as emerging enzyme mimics, offer a unique perspective for therapy through multifunctional activities, achieving essential results in the treatment of ROS‐related cardio‐ and cerebrovascular diseases by directly scavenging excess ROS or regulating pathologically related molecules. This review first introduces nanozyme‐enabled therapeutic mechanisms at the cellular level. Then, the therapies for several typical cardio‐ and cerebrovascular diseases with nanozymes are discussed, mainly including cardiovascular diseases, ischemia reperfusion injury, and neurological disorders. Finally, the challenges and outlooks for the application of nanozymes are also presented. This review will provide some instructive perspectives on nanozymes and promote the development of enzyme‐mimicking strategies in cardio‐ and cerebrovascular disease therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebrovascular DisordersCardiovascular DiseasesHumansReactive Oxygen Species

Stichwörter der Autor:innen

cardio- and cerebrovascular diseasesnanomedicinenanozymesreactive oxygen species

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • College of Engineering and Applied Sciences, Nanjing National Laboratory of Microstructures, Jiangsu Key Laboratory of Artificial Functional Materials, Nanjing University, Nanjing, Jiangsu, 210023, China.
  • Department of Chemistry and Material Science, College of Science, Nanjing Forestry University, Nanjing, Jiangsu, 210037, China.
  • State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, Nanjing, Jiangsu, 210023, China.

ORCID-Profile: Hui Wei

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Zhang, Y., Liu, W., Wang, X., Liu, Y., & Wei, H. (2023). Nanozyme‐Enabled Treatment of Cardio‐ and Cerebrovascular Diseases. Small, 19(13). https://doi.org/10.1002/smll.202204809

Vancouver

Zhang Y, Liu W, Wang X, Liu Y, Wei H. Nanozyme‐Enabled Treatment of Cardio‐ and Cerebrovascular Diseases. Small. 2023;19(13). doi:10.1002/smll.202204809

BibTeX
@article{Zhang2023,
  author = {Zhang, Yihong and Liu, Wanling and Wang, Xiaoyu and Liu, Yufeng and Wei, Hui},
  title = {Nanozyme‐Enabled Treatment of Cardio‐ and Cerebrovascular Diseases},
  journal = {Small},
  year = {2023},
  volume = {19},
  number = {13},
  doi = {10.1002/smll.202204809}
}
Kostenlos starten →